|
1
|
Cooley TB and Lee P: A series of cases of
splenomegally in children with anemia and peculiar changes. Trans
Am Pediatr Soc. 37:29–30. 1925.
|
|
2
|
Olivieri NF: The beta-thalassemias. N Engl
J Med. 341:99–109. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gringras P, Wonke B, Old J, Fitches A,
Valler D, Kuan AM and Hoffbrand V: Effect of alpha thalassaemia
trait and enhanced gamma chain production on disease severity in
beta thalassaemia major and intermedia. Arch Dis Child. 70:30–34.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weatherall DJ and Clegg JB: The
Thalassemia Syndromes (4th). Oxford: Blackwell Science Ltd.
2000.
|
|
5
|
De Sanctis V, Roos M, Gasser T, Fortini M,
Raiola G and Galati MC: Italian Working Group on Endocrine
Complications in Non-Endocrine Diseases: Impact of long-term iron
chelation therapy on growth and endocrine functions in
thalassaemia. J Pediatr Endocrinol Metab. 19:471–480.
2006.PubMed/NCBI
|
|
6
|
Najafipour F: Evaluation of endocrine
disorders in patients with thalassemia major. Int J Endocrinol
Metab. 2:104–113. 2008.
|
|
7
|
Chern JP, Lin KH, Tsai WY, Wang SC, Lu MY,
Lin DT, Lin KS and Lo SH: Hypogonadotropic hypogonadism and
hematologic phenotype in patients with transfusion-dependent
beta-thalassemia. J Pediatr Hematol Oncol. 25:880–884. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
No authors listed: Multicentre study on
prevalence of endocrine complications in thalassaemia major.
Italian Working Group on Endocrine Complications in Non-endocrine
Diseases. Clin Endocrinol (Oxf). 42:581–586. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jensen CE, Tuck SM, Old J, Morris RW,
Yardumian A, De Sanctis V, Hoffbrand AV and Wonke B: Incidence of
endocrine complications and clinical disease severity related to
genotype analysis and iron overload in patients with
beta-thalassaemia. Eur J Haematol. 59:76–81. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shamshirsaz AA, Bekheirnia MR, Kamgar M,
Pourzahedgilani N, Bouzari N, Habibzadeh M, Hashemi R, Shamshirsaz
AA, Aghakhani S, Homayoun H, et al: Metabolic and endocrinologic
complications in beta-thalassemia major: A multicenter study in
Tehran. BMC Endocr Disord. 3:42003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Classification and diagnosis of diabetes
mellitus and other categories of glucose intolerance. National
Diabetes Data Group. Diabetes. 28:1039–1057. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abdulzahra MS, Al-Hakeim HK and Ridha MM:
Study of the effect of iron overload on the function of endocrine
glands in male thalassemia patients. Asian J Transfus Sci.
5:127–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moayeri H and Oloomi Z: Prevalence of
growth and puberty failure with respect to growth hormone and
gonadotropins secretion in beta-thalassemia major. Arch Iran Med.
9:329–334. 2006.PubMed/NCBI
|
|
14
|
Mostafavi H, Afkhamizadeh M and Rezvanfar
MR: Endocrine disorders in patients with thalassemia major. Iranian
J Endocrinol Metab. 7:143–147. 2005.
|
|
15
|
De Sanctis V, Eleftheriou A and
Malaventura C: Thalassaemia International Federation Study Group on
Growth and Endocrine Complications in Thalassaemia: Prevalence of
endocrine complications and short stature in patients with
thalassaemia major: A multicenter study by the Thalassaemia
International Federation (TIF). Pediatr Endocrinol Rev. 2(Suppl 2):
249–255. 2004.PubMed/NCBI
|
|
16
|
Skordis N, Michaelidou M, Savva SC,
Ioannou Y, Rousounides A, Kleanthous M, Skordos G and Christou S:
The impact of genotype on endocrine complications in thalassaemia
major. Eur J Haematol. 77:150–156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kirti G, Pankaj A, Minakshi V, Ritu Y and
Shiksha S: Associated Complications in Beta Thalasemia Patients.
IOSR J Pharm. 3:22–25. 2013.
|
|
18
|
Soliman AT, elZalabany M, Amer M and
Ansari BM: Growth and pubertal development in transfusion-dependent
children and adolescents with thalassaemia major and sickle cell
disease: a comparative study. J Trop Pediatr. 45:23–30. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Toumba M, Sergis A, Kanaris C and Skordis
N: Endocrine complications in patients with Thalassaemia Major.
Pediatr Endocrinol Rev. 5:642–648. 2007.PubMed/NCBI
|
|
20
|
Rodda CP, Reid ED, Johnson S, Doery J,
Matthews R and Bowden DK: Short stature in homozygous
beta-thalassaemia is due to disproportionate truncal shortening.
Clin Endocrinol (Oxf). 42:587–592. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Borgna-Pignatti C, Rugolotto S, De Stefano
P, Zhao H, Cappellini MD, Del Vecchio GC, et al: Survival and
complications in patients with thalassemia major treated with
transfusion and deferoxamine. Haematologica. 89:1187–1193.
2004.PubMed/NCBI
|
|
22
|
Pantelakis S: Thyroid disorders and
diabetes mellitus as complications of thalassaemia major. Acta
Paediatr Suppl. 406:111–113. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Landau H, Matoth I, Landau-Cordova Z,
Goldfarb A, Rachmilewitz EA and Glaser B: Cross-sectional and
longitudinal study of the pituitary-thyroid axis in patients with
thalassaemia major. Clin Endocrinol (Oxf). 38:55–61. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agarwal MB, Shah S, Vishwanathan C,
Rajadhyaksha G, et al: Thyroid dysfunction in multi-transfused iron
loaded thalassemia patients. Indian Pediatr. 29:997–102.
1992.PubMed/NCBI
|
|
25
|
Magro S, Puzzonia P, Consarino C, Galati
MC, Morgione S, Porcelli D, Grimaldi S, Tancrè D, Arcuri V, De
Santis V, et al: Hypothyroidism in patients with thalassemia
syndromes. Acta Haematol. 84:72–76. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Depaz G, Deville A, Coussement N,
Manassero J and Mariani R: Thyroid function in thalassemia major.
Ann Pediatr (Paris). 32:809–811. 1985.(In French). PubMed/NCBI
|
|
27
|
Phenekos C, Karamerou A, Pipis P,
Constantoulakis M, Lasaridis J, Detsi S and Politou K: Thyroid
function in patients with homozygous beta-thalassaemia. Clin
Endocrinol (Oxf). 20:445–450. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Senanayake MP, Suraweera SA and Hubert HD:
Thyroid function in thalassaemia major. Ceylon Med J. 44:166–168.
1999.PubMed/NCBI
|
|
29
|
Sabato AR, de Sanctis V, Atti G, Capra L,
Bagni B and Vullo C: Primary hypothyroidism and the low T3 syndrome
in thalassaemia major. Arch Dis Child. 58:120–127. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
De Sanctis V, Vullo C, Bagni B and
Chiccoli L: Hypoparathyroidism in beta-thalassemia major. Clinical
and laboratory observations in 24 patients. Acta Haematol.
88:105–108. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gulati R, Bhatia V and Agarwal SS: Early
onset of endocrine abnormalities in beta-thalassemia major in a
developing country. J Pediatr Endocrinol Metab. 13:651–656. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kurtoglu AU, Kurtoglu E and Temizkan AK:
Effect of iron overload on endocrinopathies in patients with
beta-thalassaemia major and intermedia. Endokrynol Pol. 63:260–263.
2012.PubMed/NCBI
|
|
33
|
Khalifa AS, Salem M, Mounir E, El-Tawil
MM, El-Sawy M and Abd Al-Aziz MM: Abnormal glucose tolerance in
Egyptian beta-thalassemic patients: Possible association with
genotyping. Pediatr Diabetes. 5:126–132. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hussein G, Fawzy M, Serafi TE, Ismail EF,
Metwally DE, Saber MA, Giansily M, Schved JF, Pissard S and
Martinez PA: Rapid detection of beta-Thalassemia alleles in Egypt
using naturally or amplified created restriction sites and direct
sequencing: a step in disease control. Hemoglobin. 31:49–62. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiffri EH, Bogari N, Zidan KH, Teama S and
Elhawary NA: Molecular updating of β-thalassemia mutations in the
Upper Egyptian population. Hemoglobin. 34:538–547. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hussein IR, Temtamy SA, el-Beshlawy A,
Fearon C, Shalaby Z, Vassilopoulos G and Kazazian HH Jr: Molecular
characterization of beta-thalassemia in Egyptians. Hum Mutat.
2:48–52. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Novelletto A, Hafez M, Deidda G, Di Rienzo
A, Felicetti L, el-Tahan H, el Morsi Z, el-Ziny M, al-Tonbary Y,
Sittien A, et al: Molecular characterization of beta-thalassemia
mutations in Egypt. Hum Genet. 85:272–274. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Soliman OE, Yahia S, Shouma A, Shafiek HK,
Fouda AE, Azzam H, Abousamra NK, Mahfouz R, Goda EF and El-Sharawy
SA: Reverse hybridization StripAssay detection of beta-thalassemia
mutations in northeast Egypt. Hematology. 15:182–186. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Omar A, Abdel Karim E, Gendy WE, Marzouk I
and Wagdy M: Molecular basis of beta-thalassemia in Alexandria.
Egypt J Immunol. 12:15–24. 2005.PubMed/NCBI
|
|
40
|
Huisman THJ, Carver MFH and Baysal E:
Beta-thalassemia; nondeletional mutants. A syllabus of thalassemia
mutations. Huisman THJ, Carver MFH, Baysal E and Marianne FH:
(Augusta, GA). The Sickle Cell Anemia Foundation. 1–309. 1997.
|
|
41
|
Cario H, Stahnke K, Sander S and Kohne E:
Epidemiological situation and treatment of patients with
thalassemia major in Germany: results of the German multicenter
beta-thalassemia study. Ann Hematol. 79:7–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zervas A, Katopodi A, Protonotariou A,
Livadas S, Karagiorga M, Politis C and Tolis G: Assessment of
thyroid function in two hundred patients with beta-thalassemia
major. Thyroid. 12:151–154. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Najafipour F, Aliasgarzadeh A,
Aghamohamadzadeh N, Bahrami A, Mobasri M, Niafar M and Khoshbaten
M: A cross-sectional study of metabolic and endocrine complications
in beta-thalassemia major. Ann Saudi Med. 28:361–366. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gamberini MR, De Sanctis V and Gilli G:
Hypogonadism, diabetes mellitus, hypothyroidism,
hypoparathyroidism: Incidence and prevalence related to iron
overload and chelation therapy in patients with thalassaemia major
followed from 1980 to 2007 in the Ferrara Centre. Pediatr
Endocrinol Rev. 6(Suppl 1): 158–169. 2008.PubMed/NCBI
|
|
45
|
Low LC: Growth, puberty and endocrine
function in beta-thalassaemia major. J Pediatr Endocrinol Metab.
10:175–184. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yaman A, Isik P, Yarall N, Kardemir S,
Cetinkaya S, Bay A, Ozkasap S, Kara A and Tunc B: Common
complications in Beta thalasemia patients. Int J Hematol Oncol.
3:193–199. 2013. View Article : Google Scholar
|
|
47
|
Filosa A, Di Maio S, Vocca S, Saviano A,
Esposito G and Pagano L: Longitudinal monitoring of bone mineral
density in thalassemic patients. Genetic structure and
osteoporosis. Acta Paediatr. 86:342–346. 1997. View Article : Google Scholar : PubMed/NCBI
|
